Comprehensive medication guide to Lotemax including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$25–$35 copay with Bausch + Lomb Access Program at participating pharmacies for commercially insured patients; Medicare Part D typically Tier 3 — most plans require prior authorization. Medicare patients may pay as low as $79 with manufacturer Part D program.
Estimated Cash Pricing
$155–$441 retail depending on formulation (suspension, gel, ointment); as low as $49–$80 with GoodRx coupons; brand-name only for gel, ointment, and SM formulations.
Medfinder Findability Score
72/100
Summarize with AI
On this page
Lotemax is the brand name for loteprednol etabonate, a prescription ophthalmic corticosteroid (steroid eye drop) manufactured by Bausch + Lomb. First approved by the FDA in 1998, Lotemax is used to treat inflammation and pain following eye surgery, as well as a range of steroid-responsive inflammatory eye conditions including allergic conjunctivitis, ocular rosacea, iritis, and herpes zoster keratitis.
Lotemax is commonly called a "soft steroid" because it is engineered to break down rapidly into an inactive metabolite (PJ91) within the eye, limiting systemic absorption to below 1 ng/mL in clinical pharmacokinetic studies. This unique retrometabolic design gives Lotemax a significantly lower risk of steroid-induced elevated intraocular pressure compared to prednisolone acetate or dexamethasone.
Lotemax comes in multiple formulations: suspension 0.5% (eye drops), gel 0.5%, ointment 0.5%, and Lotemax SM gel 0.38% (submicron). Related branded products include Alrex (0.2% suspension for allergic conjunctivitis), Inveltys (1% suspension for post-surgical use, twice daily), and Eysuvis (0.25% for dry eye disease). Generic loteprednol etabonate suspension 0.5% is available.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Lotemax works by binding to glucocorticoid receptors (GR) inside eye cells. When activated, these receptors migrate to the cell nucleus and suppress inflammatory gene expression — reducing the production of prostaglandins, leukotrienes, and other inflammatory mediators. The result is reduced edema, decreased white blood cell migration, and suppressed scar tissue formation, which together support faster, safer healing.
What sets loteprednol apart is its retrometabolic design. Its chemical structure includes an ester at the C-20 position that is rapidly cleaved by enzymes within the eye after the drug exerts its anti-inflammatory effect. The resulting inactive metabolite (PJ91) has no glucocorticoid activity and is eliminated without systemic side effects. This is why Lotemax is significantly safer for long-term or at-risk patients than traditional ophthalmic steroids.
Lotemax SM (0.38%) uses submicron particle technology — drug particles less than 1 micron in size — that dissolve more completely in tear film, providing approximately twice the aqueous humor penetration of standard Lotemax Gel 0.5% despite a lower drug concentration. This allows effective post-surgical anti-inflammation with 3 daily doses instead of 4.
0.5% — ophthalmic suspension (eye drops)
Most widely available formulation; generic available; 1-2 drops 4x/day
0.5% — ophthalmic gel
Brand-only; invert and shake once before use; 1-2 drops 4x/day post-op
0.5% — ophthalmic ointment
Brand-only; apply 1/2 inch ribbon 4x/day post-op starting 24h after surgery
0.38% — ophthalmic gel (Lotemax SM)
Submicron gel with enhanced aqueous penetration; brand-only; 1-2 drops 3x/day post-op
As of 2026, Lotemax is not on the FDA's official drug shortage list. However, patients routinely encounter access barriers: many pharmacies stock limited quantities of specialty ophthalmic drugs, brand-only formulations (gel, ointment, SM) may not be available at smaller independent pharmacies, and high cash prices create cost-related access barriers for uninsured patients.
Insurance coverage is another major barrier — most commercial insurance plans and Medicare Part D require prior authorization for brand-name Lotemax, and many place it on Tier 3 or higher. For post-surgical patients, the time-sensitive nature of steroid eye drop regimens means these access problems can become medically urgent.
If you're having trouble finding Lotemax at your local pharmacy, medfinder can contact pharmacies near you to find which ones have it in stock — no hold music required. Results are texted directly to your phone.
Lotemax is not a controlled substance and can be prescribed by any licensed prescriber in the United States. In practice, it is most commonly prescribed by eye care specialists, though primary care providers may prescribe it for simpler allergic conjunctivitis cases.
Ophthalmologists (MD/DO): Most commonly prescribe Lotemax for post-surgical care, uveitis, and complex inflammatory eye conditions
Optometrists (OD): Licensed to prescribe topical ophthalmic steroids in all 50 U.S. states; commonly prescribe for allergic conjunctivitis and dry eye inflammation
Primary Care Physicians and Nurse Practitioners: May prescribe for simple allergic eye conditions; typically refer complex ocular inflammation to ophthalmology
Allergists: May prescribe for severe allergic conjunctivitis as part of comprehensive allergy management
Telehealth availability: For straightforward allergic conjunctivitis, some telehealth platforms can evaluate and prescribe loteprednol after a video visit. Post-surgical prescriptions and complex inflammatory conditions require in-person slit-lamp evaluation by an eye care provider.
No. Lotemax (loteprednol etabonate) is not a controlled substance and is not scheduled by the DEA. It is a prescription-only ophthalmic corticosteroid, meaning you need a valid prescription from a licensed provider to obtain it, but there are no DEA reporting requirements, no restrictions on the number of refills from a prescription standpoint (beyond your doctor's authorization), and no special pharmacy handling requirements.
You can fill Lotemax at any licensed retail pharmacy, mail-order pharmacy, or specialty pharmacy with a valid prescription. Prescriptions may be called in, faxed, or sent electronically. Prescription transfers between pharmacies are permitted without restrictions.
Lotemax is generally well-tolerated. Common mild side effects include:
Temporary stinging or burning upon instillation
Temporary blurred vision (particularly with gel and ointment formulations)
Foreign body sensation (reported in ~2% of patients)
Eye discomfort or watering
Dry eye symptoms
Elevated intraocular pressure (IOP): Risk of steroid-induced glaucoma; monitor IOP if used >10 days
Posterior subcapsular cataract formation: Risk with prolonged use
Secondary ocular infections: Immune suppression can allow bacterial, viral, or fungal infections to emerge
Delayed wound healing: Especially in corneal thinning disorders; risk of globe perforation
Know what you need? Skip the search.
Prednisolone Acetate (Pred Forte)
Workhorse post-surgical ophthalmic steroid; more potent but higher IOP risk; generic available at much lower cost
Difluprednate (Durezol)
Most potent ophthalmic steroid; convenient twice-daily dosing; highest IOP elevation risk; brand-only
Fluorometholone (FML, Flarex)
Milder steroid; lower IOP risk; generic available; better for superficial/allergic inflammation than post-surgical
Dexamethasone (Maxidex, Dextenza)
Broad-spectrum steroid; also available as office-placed intracanalicular insert (Dextenza) for compliance-challenged patients
Prefer Lotemax? We can find it.
Other ophthalmic eye drops
minorSeparate by at least 5 minutes; apply Lotemax gel/ointment last to avoid washing out other drops
Benzalkonium chloride / soft contact lenses
moderateBAK preservative in some Lotemax formulations can be absorbed by soft contact lenses; remove before use; wait 10-15 min before reinserting
Glaucoma medications (latanoprost, timolol, brimonidine)
moderateLotemax can raise IOP, potentially counteracting glaucoma medication efficacy; closer IOP monitoring required
Systemic corticosteroids (prednisone, methylprednisolone)
minorAdditive IOP effects theoretically possible; inform prescriber of all steroid use
Immunosuppressants (methotrexate, cyclosporine)
minorCombined immune suppression may increase risk of secondary ocular infections; discuss with prescriber
Lotemax (loteprednol etabonate) is a highly effective, well-tolerated ophthalmic corticosteroid that has been a cornerstone of eye care since its FDA approval in 1998. Its unique retrometabolic design makes it one of the safest steroid eye drops available — particularly important for patients at risk for steroid-induced elevated intraocular pressure, including those with glaucoma or a history of steroid response.
The main challenges with Lotemax in 2026 are access-related: high cash prices for brand-only formulations, inconsistent insurance coverage, and pharmacy-to-pharmacy stocking variability. These barriers can be navigated with manufacturer savings programs (Bausch + Lomb Access Program, bauschcopayprogram.com), discount cards like GoodRx, and proactive prior authorization by your prescriber.
If your pharmacy doesn't have Lotemax in stock, don't skip doses — especially if you've just had eye surgery. Use medfinder to find which pharmacies near you can fill your prescription quickly. Enter your medication, dosage, and location and medfinder will search nearby pharmacies and send you results by text.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards